You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

  1. Long-Acting G-CSF Analog for Treating ARS

    SBC: BOLDER BIOTECHNOLOGY INC            Topic: NIAID

    DESCRIPTION provided by applicant Development of radiological nuclear medical countermeasures to treat Acute Radiation Syndrome ARS is a high priority research area for NIAID Bone marrow is one of the most sensitive tissues to radiation damage and impaired hematopoiesis is one of the first clinical signs of excessive radiation exposure often resulting i death Granulocyte colony stimulating ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  2. DNA Vaccine Technology to Rapidly Produce Cocktails of Polyclonal Antibodies to Neutralize Lethal Viruses of Military Importance

    SBC: Aldevron            Topic: A12aT028

    In this Phase II STTR proposal we will demonstrate the scalability and ruggedness of the production system necessary for the commercialization of the goose egg-derived immunoglobulin product that is a countermeasure to the lethal (40 %) Hantavirus Pulmonary Syndrome caused by Andes Virus (ANDV). A major objective will be creating a Quality System (QS) around the global process that aligns it with ...

    STTR Phase II 2013 Department of DefenseArmy
  3. On Demand Energy Activated Liquid Decontaminants and Cleaning Solutions

    SBC: TDA Research, Inc.            Topic: A12aT005

    Decontamination of chemical and biological threats demands a very reactive solution. It is ideal to generate the decontaminants on-site: the activated decontaminant is highly reactive and quickly destroys chemical and biological warfare agents; prior to activation the ingredients can be safely stored for years, shipped, and handled. TDA's electrochemical decontamination (eClO2) technology u ...

    STTR Phase II 2013 Department of DefenseArmy
  4. A Novel Attachment Method for Legacy and Future DoD Vehicles

    SBC: Creative Engineering Solutions Inc.            Topic: A11061

    CES in cooperation with QinetiQ-NA successfully demonstrated a rapid deployment 18 thick, 24 wide x 24 tall, 400 pound applique support system that easily surpassed its Phase 1 performance requirement of 3-5 G by as much as 300%; an unprecedented 10 G (4140 pounds) of sustained static loading. CES, working with QinetiQ-NA proposes to advance and refine the technology and design during Phase II ...

    SBIR Phase II 2013 Department of DefenseArmy
  5. Energetic Surface Modification of Aluminum Nanoparticles

    SBC: TDA Research, Inc.            Topic: A12012

    Due to its favorable combustion properties, aluminum is the material of choice in metalized nanoparticle formulations for energetic materials; however, the full potential of aluminum nanoparticles has not been realized due to the presence of a nascent oxide layer (Al2O3) that surrounds the nanoparticles and retards their combustion. As a result, the military is looking for novel surface modificati ...

    SBIR Phase II 2013 Department of DefenseArmy
  6. Low-Profile Wideband SATCOM Antennas (LPWSA) for Airborne Platforms

    SBC: First RF Corporation            Topic: A11132

    FIRST RF has developed a revolutionary new dual band SATCOM antenna that provides greater than hemispherical field of view with a very low profile. The solution combines mechanical pointing with electrical pointing to support communication links over a full hemisphere while maintaining a very low profile and is optimized to fit on the RC-12 aircraft with constrained top mount installation footprin ...

    SBIR Phase II 2013 Department of DefenseArmy
  7. Long-Acting G-CSF Analog for Treating ARS

    SBC: BOLDER BIOTECHNOLOGY INC            Topic: NIAID

    DESCRIPTION (provided by applicant): Development of radiological/nuclear medical countermeasures to treat Acute Radiation Syndrome (ARS) is a high priority research area for NIAID. Bone marrow is one of the most sensitive tissues to radiation damage and impaired hematopoiesis is one of the first clinical signs of excessive radiation exposure, often resulting i death. Granulocyte colony-stimulating ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  8. Point-of-Care HIV Antigen/Antibody Diagnostic Device

    SBC: Mbio Diagnostics, Inc.            Topic: NIAID

    DESCRIPTION (provided by applicant): MBio Diagnostics, Inc. proposes to develop a low-cost, point-of-care (POC), HIV-1/2 antigen/antibody combination diagnostic device. The goal is for the Ag/Ab combo system to deliver the performance of laboratory based,4th generation antigen/antibody clinical analyzers, in a POC platform with cost and workflow of the widely used HIV rapid tests. Phase I research ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  9. Fetal Magnetocardiography Using Non-cryogenic Magnetic Field Sensors

    SBC: QUSPIN INC.            Topic: NICHD

    DESCRIPTION (provided by applicant): While the number of diagnostic technologies available for adult applications continues to grow, there remains a paucity of technologies suitable for fetal evaluation. In particular, noninvasive assessment of fetal cardiac electrophysiology has not been routinely possible despite many decades of fetal ECG research. Recently, a number of groups have demonstrated ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  10. Micro_patterned Surfaces for Reducing the Risk of Ventilator_Associated Pneumonia

    SBC: Sharklet Technologies Inc.            Topic: NHLBI

    DESCRIPTION (provided by applicant): Ventilator-associated pneumonia (VAP) is the most costly and second most common hospital-acquired infection (HAI), accounting for over 86% of hospital-acquired pneumonia (HAP). Some 300,000 HAP patients are treated annually in the U.S., at an estimated annual hospital cost of more than 1.5 billion. The current paradigm for preventing VAP has been to implement ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government